✦ LIBER ✦

Malnutrition in end stage liver disease: Recommendations and nutritional support

✍ Scribed by Eleni T Tsiaousi; Apostolos I Hatzitolios; Sotirios K Trygonis; Christos G Savopoulos

Book ID: 108951803
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 120 KB
Volume: 23
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2008.05369.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nutritional considerations in end-stage

Nutritional considerations in end-stage liver disease

✍ Simone I Strasser; Helen Vidot 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Role of nutrition in liver transplantati

Role of nutrition in liver transplantation for end-stage chronic liver disease

✍ Felix Stickel; Daniel Inderbitzin; Daniel Candinas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Clinically relevant differences in the M

Clinically relevant differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease–sodium scores

✍ Rhiana Garritsen; Andrei Tintu; Herold Metselaar; Geert Kazemier 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views

With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant

Reply: Clinically relevant differences i

Reply: Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease–sodium scores

✍ Xavier Xiol; Jose Castellote; Xavier Fuentes-Arderiu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 1 views

We thank Garritsen et al. 1 for their interest in our article about differences in Model for End-Stage Liver Disease (MELD) and Model for End-Stage Liver Disease-Sodium (MELD-Na) scores determined at 3 different laboratories. 2 We agree that one of the important messages of our article is the import

Model for end-stage liver disease except

Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system

✍ Claire Francoz; Jacques Belghiti; Denis Castaing; Olivier Chazouillères; Jean-Ch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific

Safety of invasive procedures in end-sta

Safety of invasive procedures in end-stage liver disease patients

✍ James D. Perkins 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

Patients with end-stage liver disease (ESLD) are predisposed to bleeding complications due to thrombocytopenia, reduced synthesis of coagulation factors, and increased fibrinolytic activity. The exact incidence of vascular access site and bleeding complications related to cardiac catheterization in